About us

Saving lives is in our DNA, the solution is in our proteins

Management Team

Will Dracup, CEO, the founder of the Group, has 28 years computing experience, 22 in life sciences.  He founded a company called Nonlinear Dynamics Ltd in 1989, creating the initial products and leading it throughout its 25-year history.  Nonlinear Dynamics Ltd was sold to Waters Corporation for £14.75m in cash in August 2013 at a P/E of 37. At Biosignatures, he is responsible for corporate strategy and commercialisation.  Until September 2009, Will was a Non-Executive director at IDS plc, an AIM listed diagnostics business.

Dr David Bramwell, CTO, has 22 years computing experience.  He has a First Class M.Eng in Microelectronics and Software Engineering and a PhD in human visual perception.  This was followed by postdoctoral work on human neural systems before joining Nonlinear Dynamics Ltd in 2000.  David and his research team designed Nonlinear Dynamics’ flagship analysis product Progenesis™ (launched April 2001) and created Biosignatures’ Tiger technology and MPM platforms.

Keith Milton, CFO, worked in sales for a number of years before training as a Chartered Accountant with Ernst & Young. He has 25 years finance experience and has held CFO positions in a variety of sectors.  Keith has worked in listed companies, private companies and several private equity backed businesses. He has participated in a management buyout and led two exits; a software business sold for over 10 times original investment and the second a food manufacturing business sold for a P/E multiple of 12.  Keith also has considerable operational, human resources, legal and IT experience.

Key Collaborators

Mr Rakesh Heer – Rakesh Heer is a Senior Lecturer and Honorary Consultant Urologist at the Northern Institute for Cancer Research and the Freeman Hospital. Having completed an MRC/Royal College of Surgeons of England PhD Studentship and higher surgical training in Newcastle, he became Senior Lecturer and CRUK Clinician Scientist Fellow in 2011. His clinical interests include the management and robotic surgery of prostate and bladder cancers. In addition he has a specialist interest in the treatment of male sexual dysfunction. In parallel to his clinical work, he runs a research program spanning basic science and translational biology though to randomised clinical trials. He is chief investigator on a number of national clinical trials, including those looking at biomarkers in advanced prostate cancer (NIHR VARIANT) and a large Health Technology Assessment trial of photodynamic guided treatment in non-muscle invasive bladder. Rakesh has worked closely with Biosignatures, funded by Innovate UK, to develop innovative diagnostic products for patients with bladder and prostate cancer.

Mr Naeem Soomro – Appointed as a Professor of Urology, Newcastle University in 2015. Awarded for his research in Biomarkers in Kidney & Prostate Cancer, also developing & delivering innovating ways of surgical & robotic training at the Newcastle Surgical Training Centre. Appointed as a Consultant in 1998, currently clinical lead in Urology. He has led the department in developing and delivering complex minimally invasive urological surgery. He is involved in training in minimally invasive surgery within UK and Europe. Research interest includes renal cancer, minimally invasive surgery and renal transplantation.

 

Investors